Ovarian Cancer Stocks List

Recent Signals

Date Stock Signal Type
2019-10-16 ADAP New 52 Week Closing Low Bearish
2019-10-16 ADAP NR7 Range Contraction
2019-10-16 ARAV Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-10-16 ATRA Pocket Pivot Bullish Swing Setup
2019-10-16 CTIC Expansion Pivot Buy Setup Bullish Swing Setup
2019-10-16 CTIC Crossed Above 20 DMA Bullish
2019-10-16 CTIC Pocket Pivot Bullish Swing Setup
2019-10-16 FTSV New Downtrend Bearish
2019-10-16 GENE 50 DMA Resistance Bearish
2019-10-16 GENE 20 DMA Resistance Bearish
2019-10-16 GENE Lizard Bearish Bearish Day Trade Setup
2019-10-16 GENE Doji - Bearish? Reversal
2019-10-16 GENE Shooting Star Candlestick Bearish
2019-10-16 GENE Wide Range Bar Range Expansion
2019-10-16 GENE Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-16 HARP Narrow Range Bar Range Contraction
2019-10-16 HARP NR7 Range Contraction
2019-10-16 HARP Stochastic Reached Oversold Weakness
2019-10-16 HARP Bollinger Band Squeeze Range Contraction
2019-10-16 HTBX Narrow Range Bar Range Contraction
2019-10-16 HTBX NR7 Range Contraction
2019-10-16 IMGN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-16 MYGN Stochastic Reached Overbought Strength
2019-10-16 MYGN Pocket Pivot Bullish Swing Setup
2019-10-16 NKTR Slingshot Bearish Bearish Swing Setup
2019-10-16 NKTR MACD Bullish Signal Line Cross Bullish
2019-10-16 NVCR Fell Below 20 DMA Bearish
2019-10-16 NVCR Bollinger Band Squeeze Range Contraction
2019-10-16 POAI Calm After Storm Range Contraction
2019-10-16 SLRX 20 DMA Support Bullish
2019-10-16 SLRX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-16 SLRX Bollinger Band Squeeze Range Contraction
2019-10-16 VBLT Bollinger Band Squeeze Range Contraction
2019-10-16 VBLT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-10-16 VBLT 180 Bullish Setup Bullish Swing Setup
2019-10-16 VBLT Crossed Above 20 DMA Bullish
2019-10-16 VRML Fell Below 20 DMA Bearish
2019-10-16 VRML MACD Bullish Signal Line Cross Bullish
2019-10-16 VRML Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-16 VSTM NR7 Range Contraction
2019-10-16 VSTM NR7-2 Range Contraction
2019-10-16 VSTM Narrow Range Bar Range Contraction

Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body. When this process begins, there may be no or only vague symptoms. Symptoms become more noticeable as the cancer progresses. These symptoms may include bloating, pelvic pain, abdominal swelling, and loss of appetite, among others. Common areas to which the cancer may spread include the lining of the abdomen, lymph nodes, lungs, and liver.The risk of ovarian cancer increases in women who have ovulated more over their lifetime. This includes those who have never had children, those who begin ovulation at a younger age and those who reach menopause at an older age. Other risk factors include hormone therapy after menopause, fertility medication, and obesity. Factors that decrease risk include hormonal birth control, tubal ligation, and breast feeding. About 10% of cases are related to inherited genetic risk; women with mutations in the genes BRCA1 or BRCA2 have about a 50% chance of developing the disease. The most common type of ovarian cancer, comprising more than 95% of cases, is ovarian carcinoma. There are five main subtypes of ovarian carcinoma, of which high-grade serous carcinoma is the most common. These tumors are believed to start in the cells covering the ovaries, though some may form at the Fallopian tubes. Less common types of ovarian cancer include germ cell tumors and sex cord stromal tumors. A diagnosis of ovarian cancer is confirmed through a biopsy of tissue, usually removed during surgery.Screening is not recommended in women who are at average risk, as evidence does not support a reduction in death and the high rate of false positive tests may lead to unneeded surgery, which is accompanied by its own risks. Those at very high risk may have their ovaries removed as a preventive measure. If caught and treated in an early stage, ovarian cancer is often curable. Treatment usually includes some combination of surgery, radiation therapy, and chemotherapy. Outcomes depend on the extent of the disease, the subtype of cancer present, and other medical conditions. The overall five-year survival rate in the United States is 45%. Outcomes are worse in the developing world.In 2012, new cases occurred in 239,000 women. In 2015 it was present in 1.2 million women and resulted in 161,100 deaths worldwide. Among women it is the seventh-most common cancer and the eighth-most common cause of death from cancer. The typical age of diagnosis is 63. Death from ovarian cancer is more common in North America and Europe than in Africa and Asia.

More about Ovarian Cancer